Parenteral ( Injection- Suspension) · 15µg HA* + 15µg HA* + 15µg HA* + 15µg HA* (0.5ml syringe)
These brands contain the same active ingredient and are therapeutic equivalents.
| Brand name | Dosage form | Strength | Importer | Category |
|---|---|---|---|---|
| INFLUVAC TETRA 2024/2025 | Parenteral ( Injection ) | — | POM | |
| INFLUVAC TETRA 2025 | Parenteral ( Injection- Suspension) | — | POM |